Neuropharmacology & Neurotherapeutics
Onasemnogene abeparvovec
May. 18, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
(A) The sleeve gastrectomy (SG) group included 12 women, and the control group included nine women. (B and D) Area under the curve (AUC) for concentration-time curves for both groups. Whiskers indicate the standard error of the mean. The "a" indicates that the AUC value for the sleeve gastrectomy group was significantly different from the control group at p<.05. (C) Sleeve gastrectomy and control group participants were matched on time-to-peak blood alcohol concentrations (BAC). Analysis was conducted among seven women from each group. (E and F) Individual BAC curves. (Source: Seyedsadjadi N, Acevedo MB, Alfaro R, et al. Site of alcohol first-pass metabolism among women. JAMA Netw Open 2022;5[3]:e223711. Erratum in: JAMA Netw Open 2022;5[4]:e2212773. Creative Commons Attribution 4.0 International [CC BY 4.0] license, creativecommons.org/licenses/by/4.0.)